Sweden· SE-20000727000028
Visudyne 15 mg Pulver till infusionsvätska, lösning
A medicinal product containing verteporfin, registered in Sweden by Cheplapharm Arzneimittel GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Verteporfin
- Manufacturer
- Cheplapharm Arzneimittel GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20000727000028
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Verteporfin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVisudyneOrifarm Oy
- United KingdomVerteporfin 15mg powder for solution for infusion vialsNeon Healthcare Ltd
- NorwayVisudyneCheplapharm Arzneimittel GmbH
- IrelandVisudyne 15 mg powder for solution for infusionCHEPLAPHARM Arzneimittel GmbH
- IcelandVisudyneCHEPLAPHARM Arzneimittel GmbH
- BelgiumVisudyne 15 mgCheplapharm Arzneimittel
- PolandVisudyneCHEPLAPHARM Arzneimittel GmbH
- CzechiaVISUDYNECHEPLAPHARM Arzneimittel GmbH, Greifswald
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Visudyne
- Liechtenstein · Visudyne
- Norway · Visudyne
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df4ccde9-81d1-4911-8c09-115ee4c81cd5 GET /v1/drugs/df4ccde9-81d1-4911-8c09-115ee4c81cd5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"Dispensbeslut",
"EMA",
"EPAR"
],
"se_npl_id": "20000727000028",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20000727000028",
"product_doc_link": "https://docetp.mpa.se/LMF/Visudyne%2C%20injektionsflaska%2C%2015%20mg%2C%20sammanfattning%20av%20beslut%2C%20giltigt%20fr.o.m.%202026-05-11%20t.o.m.%202027-01-31_09001bee850aa1ec.pdf"
}See everything about verteporfin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.